Australia's TGA grants approval to first objective concussion diagnostic

Oculogica

4 May 2021 - Oculogica's EyeBOX is the only objective diagnostic cleared by the US FDA and Australia TGA as an aid in diagnosis of concussion.

Oculogica announced today the Therapeutic Goods Administration of Australia granted approval to its EyeBOX technology. 

The test is for both paediatrics and adults. The technology is also patent protected in Australia.

Read Oculogica press release

Michael Wonder

Posted by:

Michael Wonder